Latest News

GM2 gangliosidoses are a group of rare inherited disorders that cause the progressive loss of nerve cells in the brain and spinal cord.

This expansion enhances its capability to produce high-potency active pharmaceutical ingredients (HPAPIs), antibody-drug conjugate (ADC) payloads, and commercial small-molecule APIs.

Tauklarify’s approval comes as the Alzheimer’s diagnostics field increasingly explores less invasive approaches, particularly blood-based tests for phosphorylated tau (pTau).

Polaroid Therapeutics designed POLTX_Fibers™ to help reduce infection risk while supporting wound healing at the point of care.

The Sepion 75 completes Syntegon’s established Sepion tablet coating range and is designed to support consistent scale-up, flexible batch processing and containment-focused manufacturing.

Healthy Horizons addresses several health priorities among older adults, including geriatric medicine, chronic disease management, vision health, sleep quality and mental wellbeing.

The new software incorporates AI-powered nodule segmentation, which is designed to generate more precise boundaries around lung nodules during pre-procedural planning.

Across Dubai, Doha, Riyadh, Muscat and other Gulf cities, physicians, dentists, nurses and other eligible healthcare professionals are encountering an increasingly diverse range of aesthetic treatments.

Rather than creating entirely new programmes, HPPI has worked to strengthen TB services within established HIV platforms while using a person-centred, community-led approach.

The company recorded non-IFRS net profit of RMB 97.23 million (US$13.7 million), while its IFRS net loss narrowed 98% year-on-year. Everest ended the period with RMB 1.859 billion (US$261.8 million) in cash.